New Guidance on Chronic Insomnia Treatment
Conexiant
April 15, 2026
Cognitive behavioral therapy for insomnia (CBT-I) is the preferred first-line treatment for chronic insomnia disorder in adults.
Combination therapy of CBT-I and pharmacotherapy offers modest benefits over medication alone but not over CBT-I alone.
Combination treatment may lead to small improvements in insomnia severity and sleep continuity but has slightly higher adverse effects.
Pharmacotherapy alone is appropriate when CBT-I is unavailable or when patients cannot engage in behavioral interventions.
The guideline emphasizes shared decision-making and tailoring treatment based on patient preferences and access to care.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: